Krajska zdravotni a.s.
- Address
- lock Available on a paid plan
Krajska zdravotni a.s. - Pediatric Infectious Disease Research
Krajska zdravotni a.s. is a clinical research center with specialized expertise in pediatric infectious disease studies. The facility focuses on advancing treatment options for serious bacterial infections in children and adolescents, with particular emphasis on gram-negative bacterial infections that pose significant therapeutic challenges in pediatric populations.
- Hospital-acquired and ventilator-associated pneumonia in pediatric patients
- Complicated intra-abdominal and urinary tract infections
- Bloodstream infections caused by gram-negative bacteria
- Pharmacokinetic studies of antimicrobial agents in children
The center demonstrates commitment to evaluating novel antibiotic combinations and their pharmacokinetic profiles across different pediatric age groups, from infants as young as 9 months through adolescents under 18 years of age. Their research contributes to optimizing antimicrobial therapy and improving safety outcomes for vulnerable pediatric populations facing serious bacterial infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pfizer Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Krajska zdravotni a.s.
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amikacin | 1 | Unknown | 2023-04-24 | 2023-04-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.